Aditya Birla Sun Life AMC (ABSLAMC) Q4 13/14 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 13/14 earnings summary
14 Oct, 2026Executive summary
FY14 profit after tax rose to ₹1,056.4m from ₹873.1m; revenue from operations reached ₹4,886.1m from ₹3,963.9m.
Auditors issued an unqualified opinion, finding the financial statements gave a true and fair view under Indian accounting principles.
Financial highlights
Total income was ₹5,138.9m vs ₹4,350.5m; profit before tax was ₹1,512.3m vs ₹1,213.7m.
Total expenses rose to ₹3,626.7m from ₹3,136.8m; scheme expenses were ₹1,802.1m vs ₹1,433.7m.
Other income fell to ₹252.9m from ₹386.6m, including lower interest income on non-current investments.
Operating cash flow was ₹1,050.1m vs ₹628.2m; cash and cash equivalents ended at ₹24.3m vs ₹40.7m.
Segment performance
Operations comprised asset management and portfolio management services; these were treated as one segment, Asset Management Services.
Management and advisory fees were ₹4,631.9m vs ₹3,712.4m; portfolio management fees were ₹40.4m vs ₹37.6m.
Real estate fund management fees were ₹213.8m vs ₹213.9m.
Latest events from Aditya Birla Sun Life AMC
- MF QAAUM grew 4%, while Q2 PBT and PAT declined YoY.ABSLAMC
Q2 26/27 - AUM rose 30%, while net profit and EPS declined as costs and depreciation climbed.ABSLAMC
Q4 06/07 - Higher fee income was outweighed by surging costs, sharply reducing FY08 profit.ABSLAMC
Q4 07/08 - FY09 income and profit rose as redemption-related scheme costs and policy changes shaped results.ABSLAMC
Q4 08/09 - FY11 profit after tax reached ₹845.4m, with EPS of ₹46.97.ABSLAMC
Q4 10/11 - FY10 PAT climbed to Rs 484.5m, while a policy change cut PBT by Rs 67.0m.ABSLAMC
Q4 09/10 - Lower revenue and earnings, higher other income, and substantial unresolved tax disputes.ABSLAMC
Q4 11/12 - FY17 revenue and profit grew, while brokerage costs and investment gains stood out.ABSLAMC
Q4 16/17 - FY16 profit after tax rose to ₹2.095bn, with a major service-tax dispute still under appeal.ABSLAMC
Q4 15/16